Investing.com -- Viking Therapeutics (NASDAQ:VKTX) stock surged 11.63% after the company announced plans to advance its experimental oral obesity drug VK2735 into late-stage trials in the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results